Dr. Severin Schwan
Chairman, Genentech Board of Directors
Chief Executive Officer, Roche Group
Prof. Sir John Irving Bell
Chief Executive Officer, Genentech and Head of North American Commercial Operations
Dr. Alan Hippe
Chief Financial Officer, Roche Group
Richard P. Lifton, M.D., Ph.D.
Chair of the Department of Genetics, Sterling Professor of Genetics and Internal Medicine
Executive Director, Yale Center for Genome Analysis
Investigator of the Howard Hughes Medical Institute at Yale University School of Medicine
CEO Roche Pharmaceuticals
Frederick C. Kentz, III
Senior Vice President, Secretary and Chief Compliance Officer, Head of Legal Affairs, North America
We've been named to Fast Company's list of "The World's 50 Most Innovative Companies" list for making targeted, genetics-based cancer therapies.